-
- 抗原 See all PLA2G16 抗体
- PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))
-
抗原表位
- AA 68-162
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This PLA2G16 antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 原理
- PLA2G16 Rabbit pAb
- 序列
- VAGSDKYQVN NKHDDKYSPL PCSKIIQRAE ELVGQEVLYK LTSENCEHFV NELRYGVARS DQVRDVIIAA SVAGMGLAAM SLIGVMFSRN KRQKQ
- 交叉反应
- 人
- 产品特性
- Polyclonal Antibodies
- 纯化方法
- Affinity purification
- 免疫原
- Recombinant fusion protein containing a sequence corresponding to amino acids 68-162 of human PLA2G16 (NP_009000.2).
- 亚型
- IgG
- Top Product
- Discover our top product PLA2G16 Primary Antibody
-
anti-HRAS-Like Suppressor 3 (PLA2G16) (AA 1-162) antibody
PLA2G16 适用: 人 WB, IF, IP 宿主: 兔 Polyclonal unconjugated
anti-HRAS-Like Suppressor 3 (PLA2G16) (AA 1-162) antibodyPLA2G16 适用: 人 WB, IF 宿主: 小鼠 Polyclonal unconjugated
anti-HRAS-Like Suppressor 3 (PLA2G16) (AA 1-162) antibodyPLA2G16 适用: 人 ELISA, WB 宿主: 小鼠 Monoclonal 4C4-2A11 unconjugated
anti-HRAS-Like Suppressor 3 (PLA2G16) (AA 1-132) antibodyPLA2G16 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-HRAS-Like Suppressor 3 (PLA2G16) antibodyPLA2G16 适用: 人, 小鼠, 大鼠 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-HRAS-Like Suppressor 3 (PLA2G16) (AA 104-132), (C-Term) antibodyPLA2G16 适用: 人, 小鼠 WB, FACS 宿主: 兔 Polyclonal RB15054 unconjugated
-
- 应用备注
- WB,1:500 - 1:2000
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C. Avoid freeze / thaw cycles.
-
- 抗原
- PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))
- 别名
- PLA2G16 (PLA2G16 产品)
- 别名
- HRASLS3 antibody, HREV107 antibody, HRSL3 antibody, AdPLA antibody, H-REV107-1 antibody, HREV107-1 antibody, HREV107-3 antibody, C78643 antibody, Hrasls3 antibody, Hrev107 antibody, MLP-3 antibody, phospholipase A2 group XVI antibody, phospholipase A2, group XVI antibody, PLA2G16 antibody, Pla2g16 antibody
- 背景
- Exhibits both phospholipase A1/2 and acyltransferase activities. Shows phospholipase A1 (PLA1 and A2 (PLA2 activity, catalyzing the calcium-independent release of fatty acids from the sn-1 or sn-2 position of glycerophospholipids. For most substrates, PLA1 activity is much higher than PLA2 activity. Shows O-acyltransferase activity,catalyzing the transfer of a fatty acyl group from glycerophospholipid to the hydroxyl group of lysophospholipid. Shows N-acyltransferase activity, catalyzing the calcium-independent transfer of a fatty acyl group at the sn-1 position of phosphatidylcholine (PC and other glycerophospholipids to the primary amine of phosphatidylethanolamine (PE, forming N-acylphosphatidylethanolamine (NAPE, which serves as precursor for N-acylethanolamines (NAEs. Exhibits high N-acyltransferase activity and low phospholipase A1/2 activity. Required for complete organelle rupture and degradation that occur during eye lens terminal differentiation, when fiber cells that compose the lens degrade all membrane-bound organelles in order to provide lens with transparency to allow the passage of light. Organelle membrane degradation is probably catalyzed by the phospholipase activity (By similarity.,PLA2G16,AdPLA,H-REV107,H-REV107-1,HRASLS3,HREV107,HREV107-1,HREV107-3,HRSL3,Cancer,Tumor suppressors,PLA2G16
- 分子量
- 18kDa
- 基因ID
- 11145
- UniProt
- P53816
- 途径
- Inositol Metabolic Process
-
You are here:
